An Open-label, Single Ascending-dose, Pharmacokinetic and Safety Study of Regadenoson (Rapidscan®) in Paediatric Patients with Cardiovascular Conditions and Diseases
100 Clinical Results associated with Rapidscan Pharma Solutions EU Ltd.
0 Patents (Medical) associated with Rapidscan Pharma Solutions EU Ltd.
100 Deals associated with Rapidscan Pharma Solutions EU Ltd.
100 Translational Medicine associated with Rapidscan Pharma Solutions EU Ltd.